Notice Information
Notice Title
Requirement For Producer Cell Line For GMP Viral Vector Packaging
Notice Description
The Clinical Biotechnology Centre (CBC) has recently validated a GMP-compliant recombinant adeno-associated viral vector (rAAV) manufacturing platform process to support UK academic clients in transitioning their gene therapy programmes from research into human clinical trials. The work took over four years of intensive effort, including initial process development, iterative process optimisation and scale-up to ensure suitability for GMP technology transfer. Critical starting and raw materials were selected and approved for use on the platform, as well as determining the optimal process parameters to ensure consistent performance. The validated platform process is now installed within the CBC's GMP clean room viral vector manufacturing suites. As rAAV manufacturing is inherently complex, technically demanding, and highly sensitive to changes in process conditions, any modification to the validated platform carries considerable risk to the quality of the products being manufactured. Even minor changes could have a significant impact to disrupt platform performance that would require months of expensive re-optimisation and re-validation activities, which would present unacceptable operational and business risks.
Procurement Information
CBC's validated GMP AAV platform being built and validated around VPC2.0 and continuity required to avoid disproportionate re-validation, delay, cost and operational risk. Only Thermo Fisher is able to grant the required rights and support for these specific cell lines, and no reasonable alternative exists without disproportionate consequences.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-0680f1
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/033233-2026
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- UK5 - Transparency Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Direct
- Procurement Method Details
- Direct award
- Tender Suitability
- SME
- Awardee Scale
- SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
85 - Health and social work services
-
- CPV Codes
85100000 - Health services
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- £180,000 £100K-£500K
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 13 Apr 20261 weeks ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 13 Apr 20261 weeks ago
- Contract Period
- 19 Apr 2026 - 31 Mar 2033 Over 5 years
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Complete
- Awards Status
- Pending
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS BLOOD AND TRANSPLANT
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- BRISTOL
- Postcode
- BS34 7QH
- Post Town
- Bristol
- Country
- England
-
- Major Region (ITL 1)
- TLK South West (England)
- Basic Region (ITL 2)
- TLK5 West of England
- Small Region (ITL 3)
- TLK52 Bath & North East Somerset and South Gloucestershire
- Delivery Location
- Not specified
-
- Local Authority
- South Gloucestershire
- Electoral Ward
- Filton
- Westminster Constituency
- Filton and Bradley Stoke
Further Information
Notice Documents
-
https://www.find-tender.service.gov.uk/Notice/033233-2026
13th April 2026 - Transparency notice on Find a Tender
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-0680f1-2026-04-13T12:23:57+01:00",
"date": "2026-04-13T12:23:57+01:00",
"ocid": "ocds-h6vhtk-0680f1",
"initiationType": "tender",
"parties": [
{
"id": "GB-PPON-PDBY-6395-VWBP",
"name": "NHS Blood and Transplant",
"identifier": {
"scheme": "GB-PPON",
"id": "PDBY-6395-VWBP"
},
"address": {
"streetAddress": "500 North Bristol Park",
"locality": "Bristol",
"postalCode": "BS34 7QH",
"country": "GB",
"countryName": "United Kingdom",
"region": "UKK12"
},
"contactPoint": {
"name": "Coco Otiotio",
"email": "coco.otiotio@nhsbt.nhs.uk",
"telephone": "+44 7385435288"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.nhsbt.nhs.uk/",
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
}
]
}
},
{
"id": "GB-PPON-PZVH-7765-WYMH",
"name": "Thermo Fisher Scientific",
"identifier": {
"scheme": "GB-PPON",
"id": "PZVH-7765-WYMH"
},
"address": {
"streetAddress": "3 Fountain Drive, Inchinnan Business Park",
"locality": "Paisley",
"postalCode": "PA4 9RF",
"country": "GB",
"countryName": "United Kingdom",
"region": "UKM83"
},
"contactPoint": {
"email": "tony.piper@thermofisher.com",
"telephone": "07836 278880"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme",
"vcse": false
}
}
],
"buyer": {
"id": "GB-PPON-PDBY-6395-VWBP",
"name": "NHS Blood and Transplant"
},
"tender": {
"id": "C394280",
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"title": "Requirement For Producer Cell Line For GMP Viral Vector Packaging",
"description": "The Clinical Biotechnology Centre (CBC) has recently validated a GMP-compliant recombinant adeno-associated viral vector (rAAV) manufacturing platform process to support UK academic clients in transitioning their gene therapy programmes from research into human clinical trials. The work took over four years of intensive effort, including initial process development, iterative process optimisation and scale-up to ensure suitability for GMP technology transfer. Critical starting and raw materials were selected and approved for use on the platform, as well as determining the optimal process parameters to ensure consistent performance. The validated platform process is now installed within the CBC's GMP clean room viral vector manufacturing suites. As rAAV manufacturing is inherently complex, technically demanding, and highly sensitive to changes in process conditions, any modification to the validated platform carries considerable risk to the quality of the products being manufactured. Even minor changes could have a significant impact to disrupt platform performance that would require months of expensive re-optimisation and re-validation activities, which would present unacceptable operational and business risks.",
"status": "complete",
"procurementMethod": "direct",
"procurementMethodDetails": "Direct award",
"procurementMethodRationale": "CBC's validated GMP AAV platform being built and validated around VPC2.0 and continuity required to avoid disproportionate re-validation, delay, cost and operational risk. Only Thermo Fisher is able to grant the required rights and support for these specific cell lines, and no reasonable alternative exists without disproportionate consequences.",
"lots": [
{
"id": "1",
"status": "complete",
"suitability": {
"sme": true
}
}
],
"documents": [
{
"id": "conflictOfInterest",
"documentType": "conflictOfInterest",
"description": "Not published"
}
],
"procurementMethodRationaleClassifications": [
{
"id": "singleSuppliersUniqueWorkArtPerformance"
}
]
},
"awards": [
{
"id": "1",
"title": "Producer Cell Line For GMP Viral Vector Packaging",
"status": "pending",
"value": {
"amountGross": 216000,
"amount": 180000,
"currency": "GBP"
},
"mainProcurementCategory": "services",
"aboveThreshold": true,
"suppliers": [
{
"id": "GB-PPON-PZVH-7765-WYMH",
"name": "Thermo Fisher Scientific"
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
}
],
"relatedLot": "1"
}
],
"contractPeriod": {
"startDate": "2026-04-20T00:00:00+01:00",
"endDate": "2033-03-31T23:59:59+01:00"
},
"relatedLots": [
"1"
],
"documents": [
{
"id": "033233-2026",
"documentType": "awardNotice",
"noticeType": "UK5",
"description": "Transparency notice on Find a Tender",
"url": "https://www.find-tender.service.gov.uk/Notice/033233-2026",
"datePublished": "2026-04-13T12:23:57+01:00",
"format": "text/html"
}
],
"milestones": [
{
"id": "1",
"type": "futureSignatureDate",
"dueDate": "2026-04-13T23:59:59+01:00",
"status": "scheduled"
}
]
}
],
"language": "en"
}